DICE Therapeutics, Inc. - FORM S-1 - EX-21.1 - August 25, 2021

Attached files

file filename
S-1 - S-1 - DICE Therapeutics, Inc.d134346ds1.htm
EX-23.1 - EX-23.1 - DICE Therapeutics, Inc.d134346dex231.htm
EX-10.10 - EX-10.10 - DICE Therapeutics, Inc.d134346dex1010.htm
EX-10.9 - EX-10.9 - DICE Therapeutics, Inc.d134346dex109.htm
EX-10.8 - EX-10.8 - DICE Therapeutics, Inc.d134346dex108.htm
EX-10.7 - EX-10.7 - DICE Therapeutics, Inc.d134346dex107.htm
EX-10.6 - EX-10.6 - DICE Therapeutics, Inc.d134346dex106.htm
EX-10.5 - EX-10.5 - DICE Therapeutics, Inc.d134346dex105.htm
EX-10.2 - EX-10.2 - DICE Therapeutics, Inc.d134346dex102.htm
EX-10.1 - EX-10.1 - DICE Therapeutics, Inc.d134346dex101.htm
EX-4.4 - EX-4.4 - DICE Therapeutics, Inc.d134346dex44.htm
EX-4.3 - EX-4.3 - DICE Therapeutics, Inc.d134346dex43.htm
EX-4.1 - EX-4.1 - DICE Therapeutics, Inc.d134346dex41.htm
EX-3.5 - EX-3.5 - DICE Therapeutics, Inc.d134346dex35.htm
EX-3.4 - EX-3.4 - DICE Therapeutics, Inc.d134346dex34.htm
EX-3.3 - EX-3.3 - DICE Therapeutics, Inc.d134346dex33.htm
EX-2.1 - EX-2.1 - DICE Therapeutics, Inc.d134346dex21.htm

Exhibit 21.1

SUBSIDIARIES OF THE REGISTRANT

 

Name

    Jurisdiction of
Organization		      % Ownership*  

DiCE Molecules SV, Inc.

      Delaware        100.00 % 

DiCE Alpha, Inc.

      Delaware        100.00 %